Edition:
India

Aspen Pharmacare Holdings Ltd (APNJ.J)

APNJ.J on Johannesburg Stock Exchange

14,435.00ZAc
19 Feb 2019
Change (% chg)

-382.00 (-2.58%)
Prev Close
14,817.00
Open
14,810.00
Day's High
14,840.00
Day's Low
14,327.00
Volume
755,834
Avg. Vol
1,616,453
52-wk High
29,800.00
52-wk Low
12,725.00

Select another date:

Thu, Dec 13 2018

South Africa's Aspen strikes distribution deal with U.S. drugmaker Mylan

JOHANNESBURG Aspen Pharmacare has struck a deal with U.S. generics maker Mylan to distribute a portfolio of prescription and over-the-counter drugs in Australia and New Zealand.

South Africa's Aspen launches three-in-one HIV drug

JOHANNESBURG South African drugmaker Aspen Pharmacare on Monday launched a triple-combination tablet for the treatment of HIV in the country where the virus is most prevalent.

South Africa's Aspen launches three-in-one HIV drug

JOHANNESBURG, Nov 26 South African drugmaker Aspen Pharmacare on Monday launched a triple-combination tablet for the treatment of HIV in the country where the virus is most prevalent.

South Africa’s Aspen to invest $231 million in sterile anaesthetics manufacturing

JOHANNESBURG, Oct 26 South African drug maker Aspen Pharmacare will invest an additional 3.4 billion rand ($231 million) at its Port Elizabeth plant, it said on Friday at an investment summit in Johannesburg.

Lactalis says Aspen deal to boost overseas business

PARIS Privately held French dairy group Lactalis said on Thursday its takeover of Aspen's global infant formula business would boost its presence in Latin America, Africa, Australia and Asia.

Lactalis says Aspen deal to boost overseas business

PARIS, Sept 13 Privately held French dairy group Lactalis said on Thursday its takeover of Aspen's global infant formula business would boost its presence in Latin America, Africa, Australia and Asia.

UPDATE 3-South Africa's Aspen in talks to sell infant formula unit

JOHANNESBURG, Sept 11 Aspen Pharmacare is in talks to sell its global infant formula business, it said on Tuesday, as the South African drug maker seeks to cash in on growing demand for baby milk.

South Africa's Aspen mulls sale of infant formula unit

JOHANNESBURG, Sept 11 South African drug maker Aspen Pharmacare said on Tuesday it was in discussions to sell its global infant formula business, but did not give any further details.

Select another date: